Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human Melanoma
Open Access
- 1 December 1999
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 113 (6) , 1076-1081
- https://doi.org/10.1046/j.1523-1747.1999.00776.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The inhibitors of apoptosis (IAPs) and their emerging role in cancerOncogene, 1998
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanismsCancer Letters, 1997
- Intercellular Adhesion Molecule 1 (ICAM-1) and bcl-2 Are Differentially Expressed in Early Evolving Malignant MelanomaThe American Journal of Dermatopathology, 1995
- Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma.Journal of Clinical Pathology, 1995
- bcl-2 Protein Expression in Cutaneous Malignant Melanoma and Benign Melanocytic NeviThe American Journal of Dermatopathology, 1995
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- Fibroblast Growth Factors in Normal and Malignant MelanocytesaAnnals of the New York Academy of Sciences, 1991
- A new experimental metastasis model in athymic nude mice, the human malignant melanoma loxInternational Journal of Cancer, 1988
- The Histogenesis of malignant melanoma in relation to pre‐existing pigmented lesionsJournal of Cutaneous Pathology, 1982